SecurityCEMP / Cempra, Inc. (58549G100)
President and CEOWechsler Daniel Mark
IndustryPharmaceutical Preparations
Institutional Owners90
Institutional Shares32,915,226 - 58.77%
Common Stock Shares Outstanding56,010,254 shares (as of 2018-06-30)
Institutional Value$ 217,692,000 USD
Related MLNT / Melinta Therapeutics, Inc.

Institutional Stock Ownership and Shareholders

CEMP / Cempra, Inc. Institutional Ownership

Cempra, Inc. (NASDAQ:CEMP) has 90 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 32,915,226 shares. Largest shareholders include Vatera Holdings Llc, Deerfield Management Co, Vanguard Group Inc, BlackRock Inc., First Manhattan Co, Millennium Management Llc, Sphera Funds Management Ltd., Stifel Financial Corp, Dimensional Fund Advisors Lp, and Alyeska Investment Group, L.P..
Cempra, Inc. (NASDAQ:CEMP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-10 13F-HR Cutler Group LP 36 36 0.00 0 0
2018-07-16 13F-HR FRANKLIN STREET ADVISORS INC /NC 13,050 12,650 -3.07 97 80 -17.53
2018-07-12 13F-HR OGOREK ANTHONY JOSEPH /NY/ /ADV 60 0 -100.00 0 0
2018-08-03 13F-HR Engineers Gate Manager LP 21,153 0 -100.00 157 0 -100.00
2018-08-14 13F-HR Magnetar Financial LLC 14,010 89
2018-08-10 13F-HR Teton Advisors, Inc. 15,500 19,000 22.58 115 121 5.22
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,560 0 -100.00 115 0 -100.00
2018-08-14 13F-HR Dynamic Technology Lab Private Ltd 15,218 97
2018-08-14 13F-HR TEACHERS ADVISORS INC 17,348 30,391 75.18 128 193 50.78
2018-08-14 13F-HR Alyeska Investment Group, L.P. 500,000 3,175
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 13,046 910 -93.02 97 6 -93.81
2018-08-13 13F-HR Vatera Holdings Llc 8,729,459 16,607,959 90.25 64,598 105,461 63.26
2018-08-10 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1,757 1,757 0.00 13 11 -15.38
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 11,874 73,982 523.06 88 469 432.95
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 338 2
2018-08-14 13F-HR BARCLAYS PLC Call 2,000 2,000 0.00 15 13 -13.33
2018-08-13 13F-HR Renaissance Technologies LLC 117,683 871
2018-02-09 13F-HR RidgeWorth Capital Management LLC 22,054 348
2018-08-13 13F-HR Laurion Capital Management LP 99,358 631
2018-08-10 13F-HR GABELLI FUNDS LLC 28,400 37,500 32.04 210 238 13.33
2018-08-13 13F-HR ALLIANCEBERNSTEIN L.P. 19,840 39,240 97.78 147 249 69.39
2018-08-06 13F-HR Granite Investment Partners, LLC 34,740 221
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 476,212 541,583 13.73 3,524 3,439 -2.41
2018-08-03 13F-HR SEI INVESTMENTS CO 20 0
2018-08-14 13F-HR MORGAN STANLEY 71,340 67,422 -5.49 527 428 -18.79
2018-05-11 13F-HR CITIGROUP INC Call 9,360 0 -100.00 148 0 -100.00
2018-02-14 13F-HR NUMERIC INVESTORS LLC 187,301 2,959
2018-08-14 13F-HR Man Group plc 153,541 0 -100.00 1,136 0 -100.00
2018-08-10 13F-HR VIRTUS ETF ADVISERS LLC 49,028 96,866 97.57 363 615 69.42
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 5,979 24,247 305.54 45 155 244.44
2018-08-14 13F-HR Wellington Management Group LLP 293,924 315,927 7.49 2,175 2,006 -7.77
2018-08-14 13F-HR Palo Alto Investors, LLC 50,689 50,689 0.00 375 322 -14.13
2018-08-01 13F-HR FIRST MANHATTAN CO 1,200,000 7,620
2018-08-14 13F-HR DEUTSCHE BANK AG\ 58,771 33,911 -42.30 434 214 -50.69
2018-08-14 13F-HR Point72 Asia (Hong Kong) Ltd 1,067 2,451 129.71 8 16 100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 22,400 39,200 75.00 166 249 50.00
2018-08-09 13F-HR BlackRock Inc. 857,398 1,658,275 93.41 6,344 10,530 65.98
2018-07-20 13F-HR Creative Planning 13,292 13,392 0.75 98 85 -13.27
2018-08-14 13F-HR VANGUARD GROUP INC 821,449 1,694,512 106.28 6,078 10,760 77.03
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 24,097 73,286 204.13 178 465 161.24
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 22,482 94,517 320.41 166 599 260.84
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 74,668 175,356 134.85 553 1,114 101.45
2018-08-02 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 2,476 2,476 0.00 18 16 -11.11
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Put 11,800 34,500 192.37 87 219 151.72
2018-08-14 13F-HR Eversept Partners, Llc 76,837 76,837 0.00 569 488 -14.24
2018-08-13 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 30 0 -100.00 0 0
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 35,871 6,999 -80.49 266 45 -83.08
2018-08-14 13F-HR Squarepoint Ops LLC 17,100 12,838 -24.92 127 82 -35.43
2018-07-26 13F-HR Advisornet Financial, Inc 200 200 0.00 1 1 0.00
2018-08-14 13F-HR DEERFIELD MANAGEMENT CO 3,127,846 3,995,806 27.75 23,146 25,373 9.62
2018-08-13 13F-HR WOLVERINE TRADING, LLC Put 24,800 24,800 0.00 184 184 0.00
2018-08-14 13F-HR UBS Group AG 1,754 4,197 139.28 13 27 107.69
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 4,301 4,366 1.51 32 28 -12.50
2018-08-13 13F-HR South Dakota Investment Council 129,941 105,021 -19.18 962 667 -30.67
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 2,951 652 -77.91 21,837 4,140 -81.04
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 4,780 4,980 4.18 35 32 -8.57
2018-08-14 13F-HR ELLINGTON MANAGEMENT GROUP LLC 27,300 173
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 446,713 1,161,861 160.09 3,306 7,378 123.17
2018-08-14 13F-HR STATE STREET CORP 192,671 212,479 10.28 1,429 1,348 -5.67
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 23,035 29,752 29.16 170 189 11.18
2018-08-14 13F-HR JP Morgan Chase & Co 3,281 73,548 2,141.63 25 467 1,768.00
2018-08-15 13F-HR GRANAHAN INVESTMENT MANAGEMENT INC/MA 304,191 1,932
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 17,757 0 -100.00 131 0 -100.00
2018-08-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 157,376 999
2018-08-14 13F-HR BARCLAYS PLC 10,210 6,079 -40.46 74 39 -47.30
2018-08-06 13F-HR RHUMBLINE ADVISERS 12,575 19,704 56.69 93 125 34.41
2018-05-11 13F-HR CITIGROUP INC 2,142 5,084 137.35 33 38 15.15
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 56,490 3,627 -93.58 418 23 -94.50
2018-08-14 13F-HR/A Monashee Investment Management LLC 2,506
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 7,939 7,908 -0.39 58 50 -13.79
2018-08-13 13F-HR Stonepine Capital Management, LLC 52,200 331
2018-08-10 13F-HR Legal & General Group Plc 2,646 2,646 0.00 20 17 -15.00
2018-08-13 13F-HR WOLVERINE TRADING, LLC 26,021 26,021 0.00 193 193 0.00
2018-08-13 13F-HR Wealthcare Advisory Partners LLC 325 2
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 9,380 32,300 244.35 69 205 197.10
2018-08-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 27,200 173
2018-08-10 13F-HR GAMCO INVESTORS, INC. ET AL 15,980 101
2018-08-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,620 0 -100.00 108 0 -100.00
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 771 1,977 156.42 6 13 116.67
2018-08-13 13F-HR Boenning & Scattergood, Inc. 23,750 151
2018-07-11 13F-HR Pennsylvania Trust Co 299,420 265,727 -11.25 2,216 1,687 -23.87
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,285 0 -100.00 150 0 -100.00
2018-09-18 13F-HR/A NORTHERN TRUST CORP 166,112 253,587 52.66 1,229 1,610 31.00
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 139,823 349,151 149.71 1,034 2,217 114.41
2018-08-03 13F-HR Financial Architects, Inc 160 160 0.00 1 1 0.00
2018-07-26 13F-HR Sterling Investment Advisors, Ltd. 95 95 0.00 1 0 -100.00
2018-08-08 13F-HR US BANCORP \DE\ 218 0 -100.00 2 0 -100.00
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 9,669 12,665 30.99 72 80 11.11
2018-08-13 13F-HR SPHERA FUNDS MANAGEMENT LTD. 243,896 984,492 303.65 1,805 6,252 246.37
2018-08-10 13F-HR ClariVest Asset Management LLC 64,800 412
2018-08-13 13F-HR GROUP ONE TRADING, L.P. 4,269 27
2018-08-10 13F-HR FEDERATED INVESTORS INC /PA/ 550 0 -100.00 4 0 -100.00
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 39,240 99,340 153.16 290 631 117.59
2018-08-06 13F-HR STRS OHIO 4,300 0 -100.00 31 0 -100.00
2018-08-10 13F-HR CITIGROUP INC 5,084 0 -100.00 38 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 200 200 0.00 1 1 0.00
2018-08-14 13F-HR STIFEL FINANCIAL CORP 151,415 571,325 277.32 1,120 3,627 223.84
2018-08-08 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 600 600 0.00 4 4 0.00
2018-08-10 13F-HR ONTARIO TEACHERS PENSION PLAN BOARD 14,537 14,537 0.00 0 0
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 100 0 -100.00 1 0 -100.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 200 200 0.00 1 1 0.00
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 10,052 15,504 54.24 74 98 32.43
2018-07-30 13F-HR SIMPLEX TRADING, LLC 607 3
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 86,300 39,100 -54.69 639 248 -61.19
2018-08-14 13F-HR Cubist Systematic Strategies, LLC 9,000 15,079 67.54 67 96 43.28
2018-08-14 13F-HR ROYAL BANK OF CANADA 27 155 474.07 0 1
2018-08-14 13F-HR A.R.T. Advisors, LLC 19,260 0 -100.00 142 0 -100.00
2018-05-11 13F-HR CITIGROUP INC Put 2,800 100 -96.43 44 1 -97.73
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 72 72 0.00 0 0
2018-07-20 13F-HR MCF Advisors LLC 400 400 0.00 3 3 0.00
2018-08-10 13F-HR CITIGROUP INC Put 100 0 -100.00 1 0 -100.00

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 58549G100